Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Clinical and Genetic Delineation of Autosomal Recessive and Dominant Actl6b-Related Developmental Brain Disorders Publisher Pubmed



Cali E1 ; Quirin T2 ; Rocca C1 ; Efthymiou S1 ; Riva A3 ; Marafi D4, 5 ; Zaki MS6 ; Suri M7, 8 ; Dominguez R9 ; Elbendary HM6 ; Alavi S1, 10 ; Abdelhamid MS11 ; Morsy H1, 12 ; Mauthem FT13, 14 Show All Authors
Authors
  1. Cali E1
  2. Quirin T2
  3. Rocca C1
  4. Efthymiou S1
  5. Riva A3
  6. Marafi D4, 5
  7. Zaki MS6
  8. Suri M7, 8
  9. Dominguez R9
  10. Elbendary HM6
  11. Alavi S1, 10
  12. Abdelhamid MS11
  13. Morsy H1, 12
  14. Mauthem FT13, 14
  15. Nizon M15, 16
  16. Tesner P17
  17. Ryba L17
  18. Zafar F18
  19. Rana N18
  20. Saadi NW19
  21. Firoozfar Z10
  22. Gencpinar P20
  23. Unay B21
  24. Ustun C21
  25. Bruel AL22, 23
  26. Coubes C24
  27. Stefanich J25
  28. Sezer O26
  29. Agolini E27
  30. Novelli A27
  31. Vasco G28
  32. Lettori D28
  33. Milh M29
  34. Villard L30
  35. Zeidler S31
  36. Opperman H32
  37. Strehlow V32
  38. Issa MY6
  39. El Khassab H33
  40. Chand P34
  41. Ibrahim S34
  42. Rashidinezhad A35, 36
  43. Miryounesi M37
  44. Larki P37
  45. Morrison J38
  46. Cristian I38
  47. Thiffault I39, 40, 41
  48. Bertsch NL42
  49. Noh GJ43
  50. Pappas J44, 45
  51. Moran E46
  52. Marinakis NM47
  53. Traegersynodinos J47
  54. Hosseini S48
  55. Abbaszadegan MR49
  56. Caumes R50
  57. Vissers LELM51, 52
  58. Neshatdoust M53
  59. Montazer Zohour M54
  60. El Fahime E55
  61. Canavati C56
  62. Kamal L56
  63. Kanaan M56
  64. Askander O57
  65. Voinova V58, 59
  66. Levchenko O60
  67. Haider S61
  68. Halbach SS62
  69. Elias Maia R63
  70. Mansoor S64, 65
  71. Jain V66
  72. Tawde S67
  73. Challa VSR68
  74. Gowda VK68
  75. Srinivasan VM68
  76. Victor LA69
  77. Pinerobanos B70
  78. Hague J71
  79. Elawady HA72
  80. Maria De Miranda Henriquessouza A73
  81. Cheema HA74
  82. Anjum MN74
  83. Idkaidak S75
  84. Alqarajeh F76
  85. Atawneh O76
  86. Morshaked H77
  87. Harel T77
  88. Zifarelli G78
  89. Bauer P78
  90. Kok F79
  91. Kitajima JP79
  92. Monteiro F79
  93. Josahkian J79
  94. Lesca G80, 81
  95. Chatron N80, 81
  96. Ville D82
  97. Murphy D83
  98. Neul JL84
  99. Mullegama SV85
  100. Begtrup A85
  101. Herman I86
  102. Mitani T4
  103. Posey JE4
  104. Tay CG87
  105. Javed I88
  106. Carr L89
  107. Kanani F90
  108. Beecroft F90
  109. Hane L91
  110. Abdelkreem E92
  111. Macek M17
  112. Bispo L93
  113. Elmaksoud MA94
  114. Hashemigorji F95
  115. Pehlivan D4, 86
  116. Amor DJ96
  117. Jamra RA32
  118. Chung WK97
  119. Ghayoor Karimiani E98, 99, 100
  120. Campeau PM101, 102
  121. Alkuraya FS103
  122. Pagnamenta AT104
  123. Gleeson JG105, 106
  124. Lupski JR4, 107, 108
  125. Striano P3, 109
  126. Morenodeluca A110
  127. Lafontaine DLJ2
  128. Houlden H1
  129. Maroofian R1

Source: Genetics in Medicine Published:2025


Abstract

Purpose: This study aims to comprehensively delineate the phenotypic spectrum of ACTL6B-related disorders, previously associated with both autosomal recessive and autosomal dominant neurodevelopmental disorders. Molecularly, the role of the nucleolar protein ACTL6B in contributing to the disease has remained unclear. Methods: We identified 105 affected individuals, including 39 previously reported cases, and systematically analyzed detailed clinical and genetic data for all individuals. Additionally, we conducted knockdown experiments in neuronal cells to investigate the role of ACTL6B in ribosome biogenesis. Results: Biallelic variants in ACTL6B are associated with severe-to-profound global developmental delay/intellectual disability, infantile intractable seizures, absent speech, autistic features, dystonia, and increased lethality. De novo monoallelic variants result in moderate-to-severe global developmental delay/intellectual disability, absent speech, and autistic features, whereas seizures and dystonia were less frequently observed. Dysmorphic facial features and brain abnormalities, including hypoplastic corpus callosum, and parenchymal volume loss/atrophy, are common findings in both groups. We reveal that in the nucleolus, ACTL6B plays a crucial role in ribosome biogenesis, particularly in pre-rRNA processing. Conclusion: This study provides a comprehensive characterization of the clinical spectrum of both autosomal recessive and dominant forms of ACTL6B-associated disorders. It offers a comparative analysis of their respective phenotypes provides a plausible molecular explanation and suggests their inclusion within the expanding category of “ribosomopathies.” © 2024 The Authors